{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:21:58Z","timestamp":1788110518328,"version":"build-2803163510"},"reference-count":42,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Psychopharmacol Clin Exp"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1002\/hup.2535","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T04:46:39Z","timestamp":1462509999000},"page":"268-285","source":"Crossref","is-referenced-by-count":36,"title":["Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis"],"prefix":"10.1002","volume":"31","author":[{"given":"Yenal","family":"Dundar","sequence":"first","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; UK"},{"name":"Mersey Care NHS Trust; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Greenhalgh","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marty","family":"Richardson","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dwan","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,5]]},"reference":[{"key":"10.1002\/hup.2535-BIB0001|hup2535-cit-0001","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and statistical manual of mental disorders: 4th ed., Text Revision (DSM-IV-TR)","author":"DSM IV: American Psychiatric Association","year":"2000"},{"key":"10.1002\/hup.2535-BIB0003|hup2535-cit-0003","first-page":"Cd007445","article-title":"Chlorpromazine for psychosis induced aggression or agitation","volume":"4","author":"Ahmed","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 14","key":"10.1002\/hup.2535-BIB0004|hup2535-cit-0004","first-page":"11","article-title":"Managing the agitated psychotic patient: a reappraisal of the evidence","volume":"61","author":"Allen","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.2535-BIB0005|hup2535-cit-0005","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4088\/JCP.10m06011yel","article-title":"Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Allen","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.2535-BIB0006|hup2535-cit-0006","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-006-0541-x","article-title":"Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol","volume":"188","author":"Andrezina","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1002\/hup.2535-BIB0007|hup2535-cit-0007","first-page":"477","article-title":"Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials","volume":"170","author":"Bhandari","year":"2004","journal-title":"CMAJ"},{"key":"10.1002\/hup.2535-BIB0008|hup2535-cit-0008","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/hup.2535-BIB0009|hup2535-cit-0009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/apt.bp.110.008318","article-title":"Treatment of acute psychotic agitation: gaps in the evidence base. Commentary on Management of Acute Agitation on Psychosis","volume":"17","author":"Brown","year":"2011","journal-title":"Adv Psychiatr Treat"},{"key":"10.1002\/hup.2535-BIB0010|hup2535-cit-0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hup.870","article-title":"An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia\/schizoaffective disorder","volume":"22","author":"Centorrino","year":"2007","journal-title":"Hum Psychopharm Clin Exp"},{"key":"10.1002\/hup.2535-BIB0011|hup2535-cit-0011","unstructured":"Centre for Reviews and Dissemination 2009 Systematic Reviews: CRDs guidance for undertaking reviews in healthcare http:\/\/www.york.ac.uk\/inst\/crd\/darefaq.htm"},{"key":"10.1002\/hup.2535-BIB0012|hup2535-cit-0012","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/B:PSAQ.0000031791.53142.85","article-title":"New treatments for agitation","volume":"75","author":"Citrome","year":"2004a","journal-title":"Psychiatric Quart"},{"key":"10.1002\/hup.2535-BIB0002|hup2535-cit-0002","volume-title":"Pocket guide to the ICD-10 classification of mental and behavioural disorders: with glossary and diagnostic criteria for research: ICD-10: DCR-10","author":"World Health Organization Geneva","year":"1994"},{"key":"10.1002\/hup.2535-BIB0013|hup2535-cit-0013","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4088\/JCP.v65n0315","article-title":"Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam","volume":"65","author":"Currier","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.2535-BIB0014|hup2535-cit-0014","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/YIC.0b013e32834fc431","article-title":"Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia","volume":"27","author":"Fang","year":"2012","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1002\/hup.2535-BIB0015|hup2535-cit-0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jclinepi.2014.12.016","article-title":"Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor","volume":"68","author":"Flacco","journal-title":"J0 Clin Epidemiol"},{"key":"10.1002\/hup.2535-BIB0016|hup2535-cit-0016","first-page":"Cd003079","article-title":"Benzodiazepines for psychosis-induced aggression or agitation","volume":"4","author":"Gillies","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/hup.2535-BIB0017|hup2535-cit-0017","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1002\/hup.2535-BIB0018|hup2535-cit-0018","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JCP.0b013e3181db8715","article-title":"Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan","volume":"30","author":"Hsu","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.2535-BIB0019|hup2535-cit-0019","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1016\/S0924-977X(12)70513-8","article-title":"Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam in the treatment of acute agitation in schizophrenia","volume":"22","author":"Hwang","year":"2012","journal-title":"J Eur College Neuropsychopharm"},{"key":"10.1002\/hup.2535-BIB0020|hup2535-cit-0020","first-page":"1","article-title":"A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation","volume":"13","author":"Katagiri","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1002\/hup.2535-BIB0021|hup2535-cit-0021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajem.2004.02.021","article-title":"Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia","volume":"22","author":"Kinon","year":"2004","journal-title":"Am J Emergen Med"},{"key":"10.1002\/hup.2535-BIB0022|hup2535-cit-0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-5618.2011.00975.x","article-title":"Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine","volume":"14","author":"Kwentus","year":"2012","journal-title":"Bipolar Disord"},{"key":"10.1002\/hup.2535-BIB0023|hup2535-cit-0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1192\/bjp.bp.110.081513","article-title":"Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine","volume":"198","author":"Lesem","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.1002\/hup.2535-BIB0024|hup2535-cit-0024","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000315437","article-title":"Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study","volume":"62","author":"Lim","year":"2010","journal-title":"Neuropsychobiology"},{"issue":"Suppl 14","key":"10.1002\/hup.2535-BIB0025|hup2535-cit-0025","first-page":"5","article-title":"The pathophysiology of agitation","volume":"61","author":"Lindenmayer","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.2535-BIB0026|hup2535-cit-0026","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania","volume":"21","author":"Meehan","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1002\/hup.2535-BIB0027|hup2535-cit-0027","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1002\/hup.2535-BIB0028|hup2535-cit-0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-9-18","article-title":"Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room","volume":"9","author":"Montoya","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"10.1002\/hup.2535-BIB0029|hup2535-cit-0029","volume-title":"CG185: Bipolar Disorder: The Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care","author":"National Institute for Health and Care Excellence","year":"2014a"},{"key":"10.1002\/hup.2535-BIB0030|hup2535-cit-0030","volume-title":"CG 178: Psychosis and Schizophrenia in Adults: Treatment and Management","author":"National Institute for Health and Care Excellence","year":"2014b"},{"key":"10.1002\/hup.2535-BIB0031|hup2535-cit-0031","volume-title":"CG25: Violence. The Short-Term Management of Disturbed\/Violent Behaviour in in-Patient Psychiatric Settings and Emergency Departments","author":"National Institute for Health and Clinical Excellence","year":"2005"},{"key":"10.1002\/hup.2535-BIB0032|hup2535-cit-0032","volume-title":"Draft Scope for the Proposed Appraisal of Loxapine Inhalation for the Treatment of Agitation in People With Schizophrenia or Bipolar Disorder","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"key":"10.1002\/hup.2535-BIB0033|hup2535-cit-0033","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/fnl.09.42","article-title":"Inhaled loxapine for acute agitation in schizophrenia and bipolar disorder","volume":"4","author":"Nordstrom","year":"2009","journal-title":"Future Neurol"},{"key":"10.1002\/hup.2535-BIB0034|hup2535-cit-0034","first-page":"Cd009377","article-title":"Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)","volume":"11","author":"Powney","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/hup.2535-BIB0035|hup2535-cit-0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archinte.1994.00420020059007","article-title":"A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis","volume":"154","author":"Rochon","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1002\/hup.2535-BIB0036|hup2535-cit-0036","first-page":"5","article-title":"A review of agitation in mental illness: burden of illness and underlying pathology","volume":"67","author":"Sachs","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.2535-BIB0037|hup2535-cit-0037","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1192\/apt.bp.109.007310","article-title":"Management of acute agitation in psychosis: an evidence-based approach in the USA","volume":"17","author":"Schleifer","year":"2011","journal-title":"Adv Psychiatr Treat"},{"key":"10.1002\/hup.2535-BIB0038|hup2535-cit-0038","unstructured":"The Nordic Cochrane Centre 2014 Review Manager (RevMan)"},{"key":"10.1002\/hup.2535-BIB0039|hup2535-cit-0039","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v68n0115","article-title":"Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Tran-Johnson","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.2535-BIB0040|hup2535-cit-0040","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","article-title":"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia","volume":"158","author":"Wright","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1002\/hup.2535-BIB0041|hup2535-cit-0041","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/JCP.0b013e3182839612","article-title":"Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia","volume":"33","author":"Zhang","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.2535-BIB0042|hup2535-cit-0042","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0b13e318033bd5e","article-title":"Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole","volume":"27","author":"Zimbroff","year":"2007","journal-title":"J Clin Psychopharmacol"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2535","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hup.2535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:26:09Z","timestamp":1625163969000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2535"}},"subtitle":["Systematic Review of Pharmacological Treatment for Psychotic Agitation"],"short-title":[],"issued":{"date-parts":[[2016,5,5]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1002\/hup.2535","archive":["Portico"],"relation":{},"ISSN":["0885-6222"],"issn-type":[{"value":"0885-6222","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,5]]}}}